tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
BBIO is currently covered by 20 analysts with an average price target of $86.99. This is a potential upside of $20.82 (31.46%) from yesterday's end of day stock price of $66.17.
BridgeBio Pharma's activity chart (see below) currently has 210 price targets and 199 ratings on display. The stock rating distribution of BBIO is 98.33% BUY and 1.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 84.45% with an average time for these price targets to be met of 266.61 days.
Highest price target for BBIO is $125, Lowest price target is $42, average price target is $82.55.
Most recent stock forecast was given by DANIELLE BRILL from TRUIST on 25-Feb-2026. First documented stock forecast 22-Jul-2019.
Currently out of the existing stock ratings of BBIO, 59 are a BUY (98.33%), 1 are a HOLD (1.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Jun-2024
$95
$28.52 (42.90%)
$86
9 days ago
(25-Feb-2026)
4/7 (57.14%)
$26.69 (39.07%)
163
Buy Since 14-May-2024
$125
$58.52 (88.03%)
$90
9 days ago
(25-Feb-2026)
4/6 (66.67%)
$56.69 (82.99%)
357
Buy Since 13-Apr-2020
$100
$33.52 (50.42%)
$90
17 days ago
(17-Feb-2026)
27/33 (81.82%)
$24.15 (31.84%)
286
Buy Since 20-Oct-2025
$98
$31.52 (47.41%)
$88
21 days ago
(13-Feb-2026)
1/4 (25%)
$22.75 (30.23%)
60
Buy Since 20-May-2021
$80
$13.52 (20.34%)
$82
1 months 6 days ago
(28-Jan-2026)
7/10 (70%)
$2.51 (3.24%)
269
What is BBIO (BridgeBio Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on BBIO (BridgeBio Pharma) with a proven track record?
Which analyst has the most public recommendations on BBIO (BridgeBio Pharma)?
Which analyst is the currently most bullish on BBIO (BridgeBio Pharma)?
Which analyst is the currently most reserved on BBIO (BridgeBio Pharma)?
